NEW YORK CITY, NY / ACCESS Newswire / March 31, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Bausch + Lomb shares tumbled in intraday trading Friday, a day after the eye-care company announced a "voluntary recall" of ...

Bronstein, Gewirtz & Grossman, LLC is currently investigating potential claims on behalf of purchasers of Bausch + Lomb (NYSE ...

J.P. Morgan analysts said it was too early to discuss the financial impact of the recall, but estimated that $70 million to ...

Most cases of TASS can be treated with steroids within a few days, although severe cases can lead to permanent damage to the ...

Bausch + Lomb (NYSE:BLCO) stock falls as the company's voluntary recall of enVista lenses leads to a downgrade at Wells Fargo ...

What Happened? Shares of eyecare company Bausch + Lomb (NYSE:BLCO) fell 6.7% in the morning session after Wells Fargo ...

Bausch + Lomb said on Thursday it will recall some of its implantable eye lenses after receiving reports of complications, ...

Bausch + Lomb has voluntarily recalled IOLs included on its enVista platform, including enVista Aspire, enVista Envy and ...

Wells Fargo downgraded Bausch + Lomb Corp to Equal Weight from Overweight on uncertainty from the voluntary recall of its enVista intraocular lenses (IOLs), which is expected to weigh on sales growth, ...

Eye health company Bausch + Lomb has issued a voluntary recall of a series of intraocular lenses, according to a March 27 ...

Bausch + Lomb has recalled its intraocular lenses after receiving reports of cases inflammation. The Canadian eyecare company said Thursday that it has made a voluntary recall of its intraocular ...